Providing Effective Opioid Dependence Treatment: Connecting Science with Treatment

Archived: Click here to access this one-hour webinar for free! Take this online CE Quiz to earn credit for your time.

Download: PowerPoint Slides, "Leaving Methadone Treatment" article by Magura and Rosenbloom, and Q & A from the Live Presentation

Description: There are three primary medications that are currently approved by the federal government for this purpose; methadone, buprenorphine and naltrexone.  This webinar will focus on how medications are used to treat chronic opioid addiction, and will include the science in support of opioid addiction treatment and changing patterns in prescription opioid use as patients enter treatment.  The presentation will respond to frequently asked questions about this treatment option in addition to discussing some of the most pressing challenges and initiatives affecting our profession.

Price: Education is FREE to all professionals

Earn Continuing Education Credit: All applicants for CE credit are required to complete and pass this online CE Quiz after viewing the webinar.  Members of NAADAC or AccuCare Subscribers receive a Certificate of Completion for 1 CE for free.  Non-members of NAADAC or Non-subscribers of AccuCare receive 1 CE for $15 (make payment here).  A CE certificate will be emailed to you within 21 days of submission and receiving payment, if applicable.  Click here for a complete list of who accepts NAADAC Continuing Education Credit.

Learning Objectives:

As a result of participating in this webinar, you will be able to:

• be able to identify evidence based practice to further patient recovery with the use of medication assisted treatment for opioid addiction;
• be better able to understand the scientific underpinnings for the use of medications to treat opioid addiction; and
• learn of the changing drug use characteristics of patients as they are admitted to Opioid Treatment Programs in the U.S.

Presenter:

Mark Parrino has been involved in the delivery of health care and substance abuse treatment since 1974. He received both a Baccalaureate in Psychology (1974) and a Masters in Health Policy, Planning and Administration (1982) from New York University.  Mr. Parrino served as the Director of the Gramercy Park Medical Group, an outpatient methadone treatment program, from 1980 to 1994. He also served as President of the National Development and Research Institutes, Inc. (NDRI) and was the Chair of New York City's Health Systems Agency's Technical Advisory Group on Substance Abuse.  Mr. Parrino served as the Chair of the Center for Substance Abuse Treatment (CSAT) Consensus Panel for State Methadone Treatment Guidelines, the first Treatment Improvement Protocol (TIP) published for national distribution.  Currently, Mr. Parrino is the President of the American Association for the Treatment of Opioid Dependence and continues to be responsible for the development and implementation of the Association's organizing initiatives. He is a consultant and educator to government, community and business groups concerning substance abuse treatment and policy. Mr. Parrino is a recipient of the Robert Wood Johnson Foundation Innovators Award for 2003.

Who Should Attend:
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists andother helping professionals that are interested in learning about addiction-related matters.

Archived: This webinar will be recorded for later viewing.  Complete the registration form to receive after the live broadcast links to the free recording and the online CE Quiz.

Technology Partner

This webinar is produced in partnership with Orion Healthcare Technology.

Questions or comments about NAADAC Education? Email This e-mail address is being protected from spambots. You need JavaScript enabled to view it

This presentation is for individual use only and may not be reproduced without permission from NAADAC.